Keyphrases

1. Portugal 100%
2. People with Vision Impairments 53%
3. Anti-vascular Endothelial Growth Factor (anti-VEGF) 50%
4. Visual Expertise 39%
5. Anti-vascular Endothelial Growth Factor Therapy 38%
6. Activity Inventory 34%
7. National Health System 33%
8. Congestive Heart Failure 32%
9. Explanatory Variables 32%
10. Visual Impairment 31%
11. Vision Impairment 31%
12. EQ-5D 29%
13. Health Outcomes 29%
14. Diabetes 29%
15. Ambulatory Care-sensitive Conditions 28%
16. Treatment Efficacy 27%
17. Vertical Integration 25%
18. Epidemiological Study 25%
19. Retrospective Analysis 25%
20. Geographical Variation 25%
21. Lost Productivity Costs 25%
22. Capture-recapture 25%
23. Administrative Data 25%
24. Geographical Factors 25%
25. Hospital Readmission 25%
26. Visual Outcome 25%
27. Productivity Loss 25%
28. Difference-in-differences Approach 25%
29. Self-adaptive Differential Evolution 25%
30. Intravitreal Injection 25%
31. Odds Ratio 25%
32. Local Health Units 25%
33. Preventable Hospitalization 25%
34. Confidence Interval 25%
35. Avoidable Admissions 25%
36. Cost-effectiveness 25%
37. Northwest Portugal 25%
38. Effect Study 25%
39. National Health Service 25%
40. Heart Failure 25%
41. Multilevel Approach 25%
42. PM10 25%
43. Sado Estuary 25%
44. Usage Patterns 25%
45. Biomonitoring 25%
46. Randomized Controlled Trial 25%
47. Vision Rehabilitation 25%
48. Rehospitalization 25%
49. Comorbidity 25%
50. Visual Acuity 20%